WallStreetZenWallStreetZen

NASDAQ: ZJYL
Jin Medical International Ltd Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Jin Medical International earnings were $3.7M for the trailing 12 months ending Sep 30, 2024, with 0% growth year over year. The latest ZJYL earnings report on Sep 30, 2024 announced Q3 2024 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2024 ending Sep 30, 2024, ZJYL reported annual earnings of $3.7M, with 27.7% growth. The next ZJYL earnings date is Jul 25, 2025.

ZJYL past earnings growth

How has ZJYL's earnings growth performed historically?

Company
0%
Industry
16.42%
Market
34.13%
ZJYL's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
ZJYL's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

ZJYL earnings history

Current Revenue
$23.5M
Current Earnings
$3.7M
Current Profit Margin
15.6%

ZJYL Return on Equity

Current Company
13.9%
Current Industry
10%
Current Market
35%
ZJYL's Return on Equity (13.9%)... subscribe to Premium to read more.
High Return on Equity Performance

ZJYL undefined

Current Company
9.3%
Current Industry
7.7%
ZJYL is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ZJYL announces earnings.

ZJYL undefined

Current Company
15.5%
Current Industry
9.9%
ZJYL's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ZJYL vs Medical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ZJYL$4.79M$3.68M0.00%$0.02
MBOT-$11.60M-$11.67MN/A-$0.65
ZTEK-$6.82M-$7.33MN/A-$0.07
INFU$21.19M$3.19M+6.96%$0.14
AKYA-$29.69M-$47.53MN/A-$0.96
View Top Medical Stocks

ZJYL earnings dates

Next earnings date
Jul 25, 2025

Jin Medical International Earnings Reports & History FAQ

What were Jin Medical International's earnings last quarter?

Jin Medical International (NASDAQ: ZJYL) reported Q3 2024 earnings per share (EPS) of N/A, up N/A year over year. Total ZJYL earnings for the quarter were N/A. In the same quarter last year, Jin Medical International's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Jin Medical International stock.

When does Jin Medical International report earnings?

The next ZJYL earnings call is Invalid Date. Add ZJYL to your watchlist to be reminded of Jin Medical International's next earnings date.

What was ZJYL's earnings growth in the past year?

As of Jin Medical International's earnings date in Q3 2025, Jin Medical International's earnings has grown 0% year over year. This is 16.42 percentage points lower than the US Medical Instruments & Supplies industry earnings growth rate of 16.42%. ZJYL earnings in the past year totalled $3.68 million.

Is Jin Medical International profitable or losing money?

As of the last Jin Medical International earnings report, Jin Medical International is currently profitable. Jin Medical International's net profit (also called net income) for the twelve months ending Sep 30, 2024 was $3.68 million, a 27.71% increase year over year.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.